Colinz Laboratories Limited (BOM:531210)
59.22
+0.97 (1.67%)
At close: Jun 18, 2026
Colinz Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 85.29 | 24 | 29.47 | 19.65 | 20.88 |
Short-Term Investments | - | 31.5 | 40.54 | 37.63 | 31.18 |
Cash & Short-Term Investments | 85.29 | 55.5 | 70 | 57.29 | 52.06 |
Cash Growth | 53.67% | -20.71% | 22.19% | 10.04% | 11.21% |
Accounts Receivable | 8.35 | 6.61 | 8.59 | 11.34 | 12.06 |
Receivables | 8.35 | 6.61 | 8.59 | 11.34 | 12.06 |
Inventory | 7.04 | 7.81 | 8.47 | 9.39 | 9.25 |
Other Current Assets | 0.09 | 20.25 | 0.29 | 0.34 | 0.42 |
Total Current Assets | 100.77 | 90.17 | 87.35 | 78.35 | 73.79 |
Property, Plant & Equipment | 15.44 | 17.01 | 15.79 | 17.09 | 18.62 |
Long-Term Investments | 11.06 | 10.44 | 10.22 | 6.63 | 6.69 |
Other Long-Term Assets | 0.54 | 0.56 | 0.24 | 0.23 | 0.21 |
Total Assets | 127.82 | 118.17 | 113.59 | 102.31 | 99.31 |
Accounts Payable | 3.83 | 5.43 | 5.98 | 6.54 | 4.75 |
Accrued Expenses | 1.32 | 9.37 | 9.73 | 8.99 | 9.43 |
Short-Term Debt | 3.9 | 6.41 | 5.7 | 2.73 | 4.85 |
Current Income Taxes Payable | - | - | - | 0.02 | 0.02 |
Other Current Liabilities | 16.61 | 0.42 | 0.42 | 0.57 | 0.78 |
Total Current Liabilities | 25.66 | 21.62 | 21.82 | 18.86 | 19.82 |
Long-Term Deferred Tax Liabilities | 1.73 | 1.81 | 2.29 | 2.06 | 2.22 |
Other Long-Term Liabilities | - | - | - | - | 0.41 |
Total Liabilities | 27.38 | 23.43 | 24.11 | 20.92 | 22.44 |
Common Stock | 25.19 | 25.19 | 25.19 | 25.19 | 35.45 |
Additional Paid-In Capital | - | 10.1 | 10.1 | 10.1 | 15.23 |
Retained Earnings | - | 34.53 | 29.57 | 24.7 | 20.13 |
Comprehensive Income & Other | 75.24 | 24.92 | 24.63 | 21.4 | 6.07 |
Shareholders' Equity | 100.43 | 94.74 | 89.49 | 81.39 | 76.87 |
Total Liabilities & Equity | 127.82 | 118.17 | 113.59 | 102.31 | 99.31 |
Total Debt | 3.9 | 6.41 | 5.7 | 2.73 | 4.85 |
Net Cash (Debt) | 81.39 | 49.09 | 64.3 | 54.55 | 47.22 |
Net Cash Growth | 65.79% | -23.65% | 17.87% | 15.54% | 28.00% |
Net Cash Per Share | 32.27 | 19.48 | 25.50 | 21.71 | 10.30 |
Filing Date Shares Outstanding | 2.52 | 2.52 | 2.52 | 2.52 | 4.57 |
Total Common Shares Outstanding | 2.52 | 2.52 | 2.52 | 2.52 | 4.57 |
Working Capital | 75.11 | 68.54 | 65.54 | 59.49 | 53.98 |
Book Value Per Share | 39.89 | 37.61 | 35.52 | 32.31 | 16.82 |
Tangible Book Value | 100.43 | 94.74 | 89.49 | 81.39 | 76.87 |
Tangible Book Value Per Share | 39.89 | 37.61 | 35.52 | 32.31 | 16.82 |
Land | - | 2.57 | 2.57 | 2.57 | 2.57 |
Buildings | - | 30.61 | 30.61 | 30.61 | 30.61 |
Machinery | - | 31.14 | 28.56 | 28.56 | 35.95 |